Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

NCT01459419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: anti-CD3 monoclonal antibody
DRUG: Sodium Chloride placebo

Sponsor

Inspira Medical AB

Collaborators

[object Object]